SeaStar Medical Issued U.S. Patent No. 11,866,730 With Broad Claims Covering Use Of Selective Cytopheretic Device For Subjects With Inflammatory Conditions And To Process Activated Leukocytes And Platelets

Author: Benzinga Newsdesk | January 09, 2024 09:37am

This newly issued patent covers methods for using SCD cartridges to treat inflammatory conditions by extracorporeally sequestering activated leukocytes and/or platelets and inhibiting or deactivating their inflammatory action, as well as methods for processing activated leukocytes and/or platelets. Treating inflammatory conditions requires controlling the number of leukocytes and/or platelets without removing too many cells, which can harm the healing process. The patent's claimed methods require the SCD cartridge to have specific ratios of surface area for sequestering activated leukocytes and/or platelets to SCD inner volume.

Posted In: ICU